Categories: News

Celularity to Present at H.C. Wainwright Global Life Sciences Conference

Celularity to also participate in a fireside chat and panel discussion with Dr. Scott Gottlieb

FLORHAM PARK, N.J., March 09, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (“Celularity”), a clinical-stage biotechnology company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced that Robert J. Hariri, M.D., Ph.D., founder, Chairperson and Chief Executive Officer of Celularity, will present a corporate overview as well as participate in a fireside chat and panel discussion during the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021.

Corporate Presentation
A pre-recorded presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. ET on March 9, 2021.

Fireside Chat
Topic: Novel Approaches to Allogeneic Cell-Based Immunotherapy: Disruptive Applications in Oncology and Beyond
Date: March 10, 2021
Time: 12:00-1:00 p.m. ET

Panel on Gene and Cell Therapies with Dr. Scott Gottlieb
Date: March 10, 2021
Time: 3:00-4:30 p.m. ET
Webcast: Link

A video recording of the corporate presentation will be available on the “Newsroom” section of the Celularity website following the conference.

About Celularity
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placenta-derived allogeneic cell therapies, including genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address a significant unmet global need for effective, accessible, and affordable therapeutics. To learn more visit celularity.com.

Celularity Investor Contacts:
Carlos Ramirez
Celularity
carlos.ramirez@celularity.com

Alexandra Roy
Solebury Trout
aroy@troutgroup.com  

Celularity Media Contact
Jason Braco, Ph.D.
LifeSci Communications
(646)-751-4361
jbraco@lifescicomms.com

Staff

Recent Posts

Truemed and ThrivePass Partner to Expand Access to Healthcare Through HSA/FSA Dollars

New partnership empowers employees to use pre-tax dollars for functional medicine and health interventions, while…

49 minutes ago

Smart Alert Tech Announces Breakthrough Patented Technology: The World’s First “Non-Event” Notifications

ORLANDO, Fla., Jan. 13, 2026 /PRNewswire/ -- Smart Alert Tech today announces a groundbreaking advancement…

49 minutes ago

Medical Solutions CEO Rebecca Rogers Tijerino named to SIA’s Staffing 100 North America list

OMAHA, Neb., Jan. 13, 2026 /PRNewswire/ -- Medical Solutions, one of the nation's leading healthcare…

49 minutes ago

Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital Health Index Twin for Chronic Disease

SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Manifold Health AI today announced its launch at JPM…

49 minutes ago

INTURAI VENTURES PROVIDES CORPORATE UPDATE

(CSE: URAI / OTC: URAIF / FSE: 3QG)                                                                                                    investor@inturai.comHighlightsU.S. OTC trading code has changed to URAIF, reflecting…

49 minutes ago

Marvin Health Debuts AI Coaches for Clinicians at J.P. Morgan Healthcare Conference

Marvin's role-specific AI coaches will augment its 24/7 therapist network for its 100+ healthcare partners…

49 minutes ago